[go: up one dir, main page]

PL2026782T3 - Kompozycje farmaceutyczne n1,n4-bis(buta-1,3-dienylo)butano-1,4-diaminy i ich zastosowania - Google Patents

Kompozycje farmaceutyczne n1,n4-bis(buta-1,3-dienylo)butano-1,4-diaminy i ich zastosowania

Info

Publication number
PL2026782T3
PL2026782T3 PL07776756T PL07776756T PL2026782T3 PL 2026782 T3 PL2026782 T3 PL 2026782T3 PL 07776756 T PL07776756 T PL 07776756T PL 07776756 T PL07776756 T PL 07776756T PL 2026782 T3 PL2026782 T3 PL 2026782T3
Authority
PL
Poland
Prior art keywords
buta
dienyl
butane
diamine
bis
Prior art date
Application number
PL07776756T
Other languages
English (en)
Inventor
Hirak S Basu
Dawn R Church
Patrick M Woster
George Wilding
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of PL2026782T3 publication Critical patent/PL2026782T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C11/00—Aliphatic unsaturated hydrocarbons
    • C07C11/02—Alkenes
    • C07C11/08—Alkenes with four carbon atoms
    • C07C11/09—Isobutene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/09—Diamines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07776756T 2006-05-03 2007-05-03 Kompozycje farmaceutyczne n1,n4-bis(buta-1,3-dienylo)butano-1,4-diaminy i ich zastosowania PL2026782T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79714206P 2006-05-03 2006-05-03
PCT/US2007/010864 WO2007130589A2 (en) 2006-05-03 2007-05-03 Nl, n4-bis (buta-i, 3-dienyl) butane-i, 4-diamine pharmaceutical compositions and uses thereof
EP07776756A EP2026782B1 (en) 2006-05-03 2007-05-03 N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and uses thereof

Publications (1)

Publication Number Publication Date
PL2026782T3 true PL2026782T3 (pl) 2013-03-29

Family

ID=38515832

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07776756T PL2026782T3 (pl) 2006-05-03 2007-05-03 Kompozycje farmaceutyczne n1,n4-bis(buta-1,3-dienylo)butano-1,4-diaminy i ich zastosowania

Country Status (18)

Country Link
US (2) US20080114072A1 (pl)
EP (1) EP2026782B1 (pl)
JP (1) JP5248483B2 (pl)
KR (1) KR20090011010A (pl)
CN (1) CN101677975B (pl)
AR (1) AR060748A1 (pl)
AU (1) AU2007248533B2 (pl)
BR (1) BRPI0711280A2 (pl)
CA (1) CA2650926C (pl)
ES (1) ES2399357T3 (pl)
IL (1) IL194994A (pl)
MX (1) MX2008013917A (pl)
NZ (1) NZ572401A (pl)
PL (1) PL2026782T3 (pl)
RU (1) RU2448693C2 (pl)
TW (1) TWI423943B (pl)
WO (1) WO2007130589A2 (pl)
ZA (1) ZA200810058B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283356B1 (en) * 2008-05-06 2014-10-22 Colgate-Palmolive Company Method of measuring effects of components on cell reactive oxygen species production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109024A (en) * 1987-02-03 1992-04-28 Merrell Dow Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
WO2000006136A2 (en) * 1998-07-31 2000-02-10 The Health Research, Inc. Therapeutic combination of polyamine with an anticancer agent
AU2001285232A1 (en) * 2000-08-24 2002-03-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Alpha-difluoromethylornithine (dfmo) use in the human prostate
AU2002345659A1 (en) * 2001-06-13 2002-12-23 The Johns Hopkins University School Of Medicine Cloned mammalian polyamine oxidase
AU2004260631B2 (en) * 2003-02-27 2009-08-06 Wisconsin Alumni Research Foundation Chroman-derivated anti-androgens for treatment of androgen-mediated disorders

Also Published As

Publication number Publication date
JP2009538280A (ja) 2009-11-05
KR20090011010A (ko) 2009-01-30
ZA200810058B (en) 2010-09-29
TWI423943B (zh) 2014-01-21
CA2650926A1 (en) 2007-11-15
JP5248483B2 (ja) 2013-07-31
WO2007130589A3 (en) 2008-03-27
IL194994A (en) 2013-10-31
CN101677975A (zh) 2010-03-24
AR060748A1 (es) 2008-07-10
WO2007130589A2 (en) 2007-11-15
IL194994A0 (en) 2009-08-03
AU2007248533A1 (en) 2007-11-15
US20140179798A1 (en) 2014-06-26
EP2026782A2 (en) 2009-02-25
CA2650926C (en) 2014-07-08
RU2008147658A (ru) 2010-06-10
AU2007248533B2 (en) 2012-03-15
CN101677975B (zh) 2013-06-26
NZ572401A (en) 2011-08-26
EP2026782B1 (en) 2012-11-14
TW200811081A (en) 2008-03-01
BRPI0711280A2 (pt) 2012-03-06
MX2008013917A (es) 2008-11-12
RU2448693C2 (ru) 2012-04-27
HK1129580A1 (en) 2009-12-04
US20080114072A1 (en) 2008-05-15
ES2399357T3 (es) 2013-03-27

Similar Documents

Publication Publication Date Title
GB2434312B (en) Cannabinoid-containing plant extracts as neuroprotective agents
IL230759A0 (en) Converted acyl anilide, the pharmaceutical composition containing it and its uses
EP2076604A4 (en) GLP-2 MIMIC BODIES, POLYPEPTIDES, COMPOSITIONS, PROCESSES AND USES
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
GB0819507D0 (en) Aqueous primer composition
EP2044647A4 (en) REDOX COUPLING COMPOSITIONS AND USES THEREOF
PL2035047T3 (pl) Kompozycja macierzy zewnątrzkomórkowej
GB0706077D0 (en) Methods, Compositions and uses thereof
EP2187872A4 (en) EXTENDED RELEASE COMPOSITIONS COMPRISING SODIUM MYCOPHENOLATE AND METHODS RELATING THERETO
GB0601143D0 (en) Uses, methods and compositions
GB0703230D0 (en) Turbine
IL193384A0 (en) Substituted prolinamides, their preparation and their use as pharmaceuticals
PT1956128E (pt) Entretela elástica, processo para a sua produção e utilização
GB0622399D0 (en) Novel compositions and uses thereof
GB0716048D0 (en) Roofing components
GB0715428D0 (en) Compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof
PL2026782T3 (pl) Kompozycje farmaceutyczne n1,n4-bis(buta-1,3-dienylo)butano-1,4-diaminy i ich zastosowania
ZA201006443B (en) Novel immunoregularory peptides,compositions and uses thereof
IL207174A0 (en) Peptides, compositions, and uses thereof
GB0701171D0 (en) Compositions and uses thereof
EP2010141A4 (en) NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF
GB0622400D0 (en) Novel compositions and uses thereof
EP2204173A4 (en) PHARMACEUTICAL COMPOSITION HAVING ANTIDIABETIC EFFECT
GB0725264D0 (en) Compositions and uses thereof